Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,667
Closed -$210K 252
2025
Q4
$210K Hold
1,667
0.07% 196
2025
Q3
$244K Buy
1,667
+200
+14% +$30.2K 0.08% 181
2025
Q2
$229K Sell
1,467
-200
-12% -$31.7K 0.09% 183
2025
Q1
$275K Hold
1,667
0.12% 149
2024
Q4
$272K Sell
1,667
-53
-3% -$9.48K 0.1% 172
2024
Q3
$336K Sell
1,720
-100
-5% -$18.4K 0.12% 150
2024
Q2
$316K Sell
1,820
-447
-20% -$74.4K 0.11% 144
2024
Q1
$384K Hold
2,267
0.14% 128
2023
Q4
$448K Hold
2,267
0.17% 118
2023
Q3
$394K Hold
2,267
0.19% 109
2023
Q2
$390K Hold
2,267
0.17% 119
2023
Q1
$377K Hold
2,267
0.19% 117
2022
Q4
$332K Buy
2,267
+79
+4% +$11.7K 0.19% 123
2022
Q3
$324K Sell
2,188
-25
-1% -$4.18K 0.2% 110
2022
Q2
$380K Hold
2,213
0.23% 100
2022
Q1
$417K Sell
2,213
-23
-1% -$4.55K 0.19% 101
2021
Q4
$546K Buy
+2,236
New +$490K 0.23% 93

Other funds holding ZTS

Wealth Effects's ZTS Position: Q1 2026 in Review

Wealth Effects sold out of Zoetis (ZTS) in Q1 2026, closing a stake of 1,667 shares — an estimated $210K sold.

Wealth Effects first reported a position in ZTS in Q4 2021 and held it in 17 quarters. The position peaked at $546K in Q4 2021. 1,604 funds tracked by Wall St. Rank hold ZTS as of Q1 2026.

  • Wealth Effects reported no remaining Zoetis position as of Q1 2026 after selling out during the quarter.
  • Wealth Effects sold 1,667 Zoetis shares in Q1 2026, an estimated $210K.
  • Wealth Effects first reported a position in Zoetis in Q4 2021 and held it in 17 quarters.
  • Wealth Effects's Zoetis position peaked at $546K in Q4 2021.
  • 1,604 funds tracked by Wall St. Rank held Zoetis as of Q1 2026.

Based on Wealth Effects's 13F filing for Q1 2026, filed 21 Apr 2026.